scorecardresearch
Saturday, August 9, 2025
TopicPfizer vaccine

Topic: Pfizer vaccine

8,200 syringes/min — how this Indian firm is helping in vaccinating the world against Covid

Haryana-based Hindustan Syringes & Medical Devices has been looking to meet the world's demand for syringes amid the global Covid-19 vaccination drive. 

Brazil’s hospital woes, allergic reaction to Pfizer in Japan & other global Covid-19 news

As the Covid-19 pandemic shows no signs of letting up, ThePrint highlights the most important stories on the crisis from across the globe.

Single dose of Pfizer, AstraZeneca vaccines effective, work against UK variant too — Study

The study by Public Health England aimed at arriving at a real world estimation of how effective the two vaccines are and covered all adults in England aged 70 years and above.

Will convince Modi govt to bring back Pfizer vaccine, it will add value: CSIR chief Mande

India will need at least 4 other vaccines to help finish immunisation drive faster, and J&J, Moderna, Sputnik are good options along with Pfizer, CSIR head Shekhar Mande says.

Pfizer-BioNTech vaccine could help end Covid pandemic, Israel study shows

Two doses prevented 94% of Covid-19 cases in 596,618 people vaccinated between 20 Dec and 1 Feb, teams from Clalit Research Institute and Harvard University reported in a study.

Why Pfizer’s Covid vaccine was not granted emergency use approval by govt’s expert panel

A selection of the best news reports, analysis and opinions published by ThePrint this week.

Pfizer vaccine can neutralise Covid variants first reported in UK, South Africa, study says

The research, published in Nature Medicine journal, noted that neutralisation against Covid variant carrying E484K mutation was slightly lower than that against the N501Y mutation.

Why India’s expert panel rejected Pfizer plea for emergency use nod to its Covid vaccine

The Drug Controller General of India has in the past rejected several applications from other drugmakers, including Dr Reddy Laboratory and Natco Pharma.

Pfizer withdraws application for emergency use of its Covid vaccine in India

Pfizer says it will resubmit its approval request with additional information as it becomes available in the near future.

WHO says Pfizer vaccine safe for elderly despite Norway scare

The WHO panel said reports of deaths 'are in line with the expected, all-cause mortality rates' & risk-benefit balance of the vaccine 'remains favorable in the elderly'.

On Camera

Buying Russian oil, misreading Trump—3 points will define India’s next energy strategy

India should have secured greater savings by pressing Russia for prices nearer the cap while sustaining high volumes. This would have preserved strategic autonomy and served economic logic.

Go Swadeshi—RSS affiliate SJM calls for boycott of US firms Amazon, Walmart after Trump’s tariff hike

New Delhi: The day after the US imposed a 50 percent trade tariff on India, RSS affiliate Swadeshi Jagran Manch (SJM) has made an...

Shadow war over India’s defence procurement on social media raises concerns of dodgy & undue influence

One such website has drawn particular scrutiny for spreading fake stories that have upset not only the Indian but also foreign defence firms by falsely attributing misinformation.

Pakistan, Dhaka have played Washington well. Back home, Modi ecosystem has an inner conflict

To protect ourselves from Trumpian diplomacy, first we must introspect the bipolarity within our establishment discourse.